J. Penttila et al., Spontaneous baroreflex sensitivity as a dynamic measure of cardiac anticholinergic drug effect, J AUT PHARM, 21(2), 2001, pp. 71-78
1 In this study, the analysis of spontaneous baroreflex sensitivity (BRS) w
as applied to the dynamic assessment of cardiac anticholinergic drug effect
in healthy male volunteers.
2 The anticholinergic effects of single intravenous (i.v.) injections of at
ropine (10 mug kg(-1)), glycopyrrolate (5 mug kg(-1)) and scopolamine (5 mu
g kg(-1)), as well as a 2-h infusion of glycopyrrolate (5 mug kg(-1) h(-1))
were investigated. Baroreflex sensitivity, a validated measure of cardiac
parasympathetic reflex regulation, was repeatedly measured from 5-min recor
dings of electrocardiogram (ECG) and continuous blood pressure by using the
sequence technique, a method based on detection of spontaneous fluctuation
s in blood pressure and heart rate.
3 Single injections of atropine, glycopyrrolate and scopolamine decreased t
he mean BRS by 71 +/- 32, 68 +/- 23 and 27 +/- 45%, respectively, whereas t
he slow glycopyrrolate infusion gradually decreased BRS (up to 83 +/- 11% r
eduction) and increased both systolic (SAP) and diastolic arterial pressure
s (DAP) (on an average, by 9 mmHg).
4 During the withdrawal of the parasympathetic blockade (indicated by incre
asing BRS), the proportion of baroreflex sequences in the recordings increa
sed transiently from 10 up to 20-25%, probably reflecting the restoration o
f the baroreflex integrity and the baroreflex-induced attempt to counteract
the blood pressure increase.
5 The sequence method to study BRS seems to be feasible in the assessment o
f cardiac anticholinergic drug effects, and it also provides good time reso
lution for the dynamic measurements.